Skip to main content
Heather Stefanski, MD, Pediatric Hematology & Oncology, Minneapolis, MN, M Health Fairview University of Minnesota Medical Center

HeatherEmilyStefanskiMD

Pediatric Hematology & Oncology Minneapolis, MN

Assistant Professor, Pediatrics, University of Minnesota Medical School

Dr. Stefanski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Stefanski's full profile

Already have an account?

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Pediatric Hematology/Oncology, 2007 - 2010
  • University of Minnesota
    University of MinnesotaResidency, Pediatrics, 2004 - 2007
  • University of Minnesota Medical School
    University of Minnesota Medical SchoolClass of 2004

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2006 - 2024
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Thymic Epithelial Cell Support of Thymopoiesis Does Not Require Klotho  
    Bruce R Blazar, Heather E Stefanski, Sarah L Parker, Jakub Tolar, The Journal of Immunology

Abstracts/Posters

  • Third Party Type 2 Innate Lymphoid Cells Treat and Prevent GI Tract Acute GvHD
    Heather Stefanski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Molecular Detection of Minimal Residual Disease Precedes Morphological Relapse and Could be Used to Identify Relapse in Pediatric and Young Adult B-Cell Acute Lymphobl... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Magenta Therapeutics Highlights Recent Progress and Expected Timing of 2021 Milestones, Including Four Ongoing and Planned Clinical Trials
    Magenta Therapeutics Highlights Recent Progress and Expected Timing of 2021 Milestones, Including Four Ongoing and Planned Clinical TrialsJanuary 11th, 2021
  • National Marrow Donor Program® (NMDP)/Be the Match® Partners with New York Blood Center Enterprises Comprehensive Cell Solutions and Vitalant’s Cell Therapy Lab; Expands Access to Transplant
    National Marrow Donor Program® (NMDP)/Be the Match® Partners with New York Blood Center Enterprises Comprehensive Cell Solutions and Vitalant’s Cell Therapy Lab; Expands Access to TransplantSeptember 27th, 2023

Hospital Affiliations